Mitozz is the best choice for mitochondrial support See why ➝

    End of Content.

    Shop Mitozz

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Search Papers by Specialization

    Mitochondrial Transfer and Peripheral Neuropathy

    Study Title: Mitochondrial transfer from glia to neurons protects against peripheral neuropathy

    Citation: Xu et al., 2026 · Nature

    What the Study Found: This study investigated how satellite glial cells in dorsal root ganglia support sensory neurons. The authors found that these glial cells can transfer mitochondria to sensory neurons through tunnelling nanotube-like structures, a process involving the protein MYO10. In mouse and human tissue, the researchers observed structural evidence of these glia-neuron connections. Blocking mitochondrial transfer in mice led to nerve degeneration and neuropathic pain-like behavior, while transfer of human satellite glial cells into mouse dorsal root ganglia provided MYO10-dependent protection against peripheral neuropathy. The findings suggest that mitochondrial sharing between glia and neurons may be an important protective mechanism in peripheral nerve biology.

    What this means in real life: Nerve cells have high energy demands, especially sensory neurons with long axons that must maintain function far from the cell body. This study suggests that neurons may not rely only on their own mitochondria. Nearby glial support cells may help maintain neuronal energy capacity by donating mitochondria when needed. That does not mean mitochondrial transfer is a proven treatment for neuropathy in humans, but it expands the way we think about nerve health, showing that cellular energy support can depend on cooperation between different cell types.

    Clinical Relevance: Translational study using mouse models, human dorsal root ganglion tissue, diabetic neuropathy context, mitochondrial transfer biology, and neuropathic pain mechanisms; not a human clinical trial.

    Related Content:

    View Paper

    Epicatechin and Muscle Wasting After Spinal Cord Injury

    Study Title: (-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system

    Citation: Gonzalez-Ruiz et al., 2020 · Molecular Biology Reports

    What the Study Found: This study evaluated (-)-epicatechin in a mouse model of complete spinal cord transection, a severe injury model associated with rapid skeletal muscle wasting. The authors focused on the ubiquitin-proteasome system, a major pathway involved in protein breakdown during muscle atrophy. Compared with untreated injured animals, (-)-epicatechin-treated mice showed reduced loss of muscle mass and changes in molecular markers related to protein degradation. The findings suggest that (-)-epicatechin helped blunt muscle wasting in this model by influencing proteasome-related signaling and muscle catabolism pathways.

    What this means in real life: After severe spinal cord injury, muscles can lose size and functional capacity because nerve input, movement, and normal loading are disrupted. This animal study suggests that (-)-epicatechin may affect some of the molecular pathways that drive muscle breakdown after spinal cord injury. It does not show that (-)-epicatechin treats spinal cord injury or prevents muscle loss in humans, but it adds to the scientific literature on epicatechin, neuromuscular biology, and skeletal muscle preservation under extreme disuse conditions.

    Clinical Relevance: Animal study, complete spinal cord transection model, skeletal muscle wasting, ubiquitin-proteasome signaling, and neuromuscular injury biology; not direct clinical trial evidence.

    Related Content:

    View Paper

    (+)-Epicatechin and Spinal Cord Injury Recovery

    Study Title: Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery

    Citation: Gonzalez-Ruiz et al., 2025 · Biomolecules

    What the Study Found: This study evaluated (+)-epicatechin in female Long Evans rats with moderate traumatic spinal cord injury. Animals received either vehicle or (+)-epicatechin beginning 24 hours after injury and were followed for 21 days. Compared with vehicle-treated injured rats, the (+)-epicatechin group showed better locomotor recovery on the BBB scale, including a significantly different recovery slope over time. Protein analysis also suggested protection against injury-associated changes in angiopoietin-1, beclin-1, GFAP, myelin basic protein, NeuN, and neurofilament heavy chain. Together, the results suggest that (+)-epicatechin helped limit several molecular signs of spinal cord damage progression in this experimental model.

    What this means in real life: Spinal cord injury involves more than the initial trauma. Secondary damage can affect blood vessels, glial activity, myelin, neurons, and axonal structure over time. In this animal model, (+)-epicatechin appeared to preserve several of these biological markers while supporting better movement recovery. This does not mean (+)-epicatechin is a proven treatment for spinal cord injury in humans, but it adds to the scientific interest around epicatechin-related compounds, neural protection, vascular stability, and recovery biology.

    Clinical Relevance: Rat study, moderate traumatic spinal cord injury model, locomotor recovery, neural damage markers, and protein analysis; not human clinical trial evidence.

    Related Content:

    View Paper

    Mitophagy, mtDNA Leakage, and Inflammation During Aging

    Study Title: Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging

    Citation: Jiménez-Loygorri et al., 2024 · Nature Communications

    What the Study Found: This study examined how impaired mitophagy contributes to inflammatory signaling during aging. The researchers found that age-related decline in mitophagy was associated with accumulation of mitochondrial DNA in the cytosol, where it activated the cGAS/STING pathway. In neuronal and brain-aging models, defective mitochondrial quality control increased inflammatory signaling linked to cytosolic mtDNA. The study also showed that restoring or supporting mitophagy reduced cytosolic mtDNA accumulation and helped limit cGAS/STING-associated inflammation.

    What this means in real life: This paper supports the idea that mitochondrial quality control is closely tied to inflammation during aging. When damaged mitochondria are not cleared efficiently, mitochondrial DNA can escape into places where the cell interprets it as a danger signal. That can activate immune-like inflammatory pathways, even inside tissues such as the brain. This does not mean mitophagy support treats brain aging or inflammatory disease. The practical takeaway is that mitochondrial cleanup is part of how cells maintain calm, resilient signaling over time.

    Clinical Relevance: Mechanistic aging and neurobiology study, focused on mitophagy, cytosolic mitochondrial DNA, cGAS/STING signaling, and age-associated inflammation.

    Related Content:

    View Paper

    Mitochondria and Mood

    Study Title: Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression

    Citation: Allen et al., 2018 · Frontiers in Neuroscience

    What the Study Found: This review explains how mitochondrial dysfunction may contribute to depression biology. The authors discuss mitochondrial roles in ATP production, oxidative phosphorylation, membrane polarity, oxidative stress, apoptosis, inflammation, and neuronal plasticity. They also note that evidence on antidepressants and mitochondrial function is mixed, with some studies suggesting no benefit or added dysfunction, while others suggest potentially beneficial effects.

    What this means in real life: This paper helps explain why mood and energy can be biologically connected. Depression is not only about emotions or neurotransmitters. The brain has high energy demands, and when mitochondrial function is strained, cellular energy, stress signaling, inflammation, and brain plasticity may all be affected. This does not mean mitochondria explain every case of depression, but it supports the idea that cellular energy biology is part of the larger picture.

    Clinical Relevance: Mechanistic review, depression biology, not direct clinical trial evidence.

    Related Content:

    View Paper

    Mitochondrial Metabolism in Major Depressive Disorder

    Study Title: Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options

    Citation: Larrea et al., 2024 · Journal of Clinical Medicine

    What the Study Found:
    This review examined the relationship between mitochondrial dysfunction and Major Depressive Disorder. The authors describe how changes in mitochondrial metabolism may affect energy production, oxidative stress, inflammation, neuroplasticity, and depressive symptom biology. They also discuss the possibility that mitochondrial-related biomarkers could help support earlier or more objective diagnosis, while reviewing emerging treatment approaches such as ketamine/esketamine, psychedelics, anti-inflammatory strategies, transcranial magnetic stimulation, and deep brain stimulation.

    Clinical Relevance: Review article, Major Depressive Disorder, mitochondrial dysfunction, biomarkers, oxidative stress, inflammation, emerging treatment approaches.

    What this means in real life: This paper reinforces the idea that depression is not only an emotional experience. It can also involve changes in how the brain and body regulate energy, stress, inflammation, and cellular repair. Mitochondria do not explain all depression, but they may help connect symptoms such as low energy, mental fatigue, stress sensitivity, and reduced resilience with measurable biological processes.

    View Paper

    Mitochondrial Dysfunction in Depression

    Study Title: The Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment

    Citation: Caruso et al., 2019 · Frontiers in Pharmacology.

    What the Study Found: This opinion article reviewed how mitochondrial dysfunction may be involved in depression. The authors focused on brain energy metabolism, ATP production, oxidative stress, inflammation, and the way chronic stress may affect mitochondrial function.

    The paper explains that the brain uses a large amount of energy and depends on steady mitochondrial activity. When mitochondrial energy balance is disrupted, brain cells may become less able to support normal signaling, adaptation, and resilience.

    The authors also discussed oxidative stress as an important part of the picture. Mitochondria produce ATP, but they also generate reactive oxygen and nitrogen species. When antioxidant defenses cannot keep those signals balanced, oxidative stress may contribute to depression-related biology.

    Clinical Relevance: Opinion article, neurobiology, mitochondrial dysfunction, oxidative stress, and depression research.

    What this means in real life: Depression is not caused by one single thing. This paper shows that researchers are looking at how brain cells make and manage energy as one possible part of the picture.

    Mitochondria help brain cells produce energy and handle stress. When that system is under strain, it may affect how the brain responds to inflammation, stress, and daily demands.

    This does not mean mitochondrial problems cause all depression. It also does not mean that any supplement or lifestyle change is a proven treatment. The simple takeaway is that brain energy and cellular stress are important areas of depression research.

    Related Content:

    View Paper

    Mitochondrial Dysfunction and Depression

    Study Title: Mitochondrial Dysfunction in Depression

    Citation: Bansal et al., 2016 · Current Neuropharmacology

    What the Study Found: This review examined how mitochondrial dysfunction may be involved in depression. The authors focused on how impaired cellular energy biology may affect brain function, oxidative stress, calcium signaling, neurotransmission, and neuroplasticity.

    The paper does not report a new clinical trial or intervention. Instead, it organizes existing evidence linking mitochondrial dysfunction in different brain regions with depression-related biology.

    The main relevance is that depression may involve more than neurotransmitter signaling. Energy availability, oxidative balance, and cellular stress responses may also help shape how the brain functions under emotional and physiological strain.

    Clinical Relevance: Review, neurobiology and mitochondrial dysfunction in depression research.

    What this means in real life: Depression is not caused by one single thing. This review shows that researchers are looking at how brain cells make and manage energy as one possible part of the picture.

    Mitochondria help brain cells produce energy and handle stress. When that system is not working well, it may affect how the brain responds to pressure, inflammation, and daily demands.

    This does not mean mitochondrial problems cause all depression. It also does not mean that any supplement or lifestyle change is a proven treatment. The takeaway is simple: brain energy and cellular stress are important areas of depression research.

    Related Content:

    View Paper

    Mitochondria and the Biological Need for Sleep

    Study Title: Mitochondrial origins of the pressure to sleep

    Citation: Sarnataro et al., 2025. Nature

    What the Study Found: This study found that sleep pressure may originate from mitochondrial activity inside specific brain neurons. After sleep deprivation, these neurons showed increased expression of genes involved in mitochondrial respiration and ATP production, along with structural changes like mitochondrial fragmentation and increased mitophagy. These changes were reversed with recovery sleep, suggesting that sleep helps restore mitochondrial balance.

    What this means in real life: This study suggests that the need for sleep may be directly tied to how your cells produce and manage energy. When mitochondrial activity becomes imbalanced, the brain may trigger sleep as a way to restore stability and prevent cellular stress.

    Related Content:

    • Curious how lack of sleep affects your energy at the cellular level? → What Happens to Your Mitochondria When You Don’t Sleep Enough?

    • Want to understand how cellular energy systems influence overall function and resilience? → Mitochondria: The Tiny Engines Fueling Your Life

    • Looking to understand how cellular energy connects to broader health and performance? → How Does Mitochondrial Health Define Your Body? The Real Story of Energy from Within

    View Paper

    Chronic Renal Damage, Stress Signaling, and Cellular Protection

    Study Title:
    Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model

    Citation: Montes-Rivera et al., 2019 · Heliyon

    What the Study Found: In a 5/6 nephrectomy rat model of chronic kidney disease, (−)-epicatechin modulated key biomarkers of inflammation, fibrosis, and cellular stress in the kidneys. The treatment altered several disease-progression markers. These changes suggest a slowing of the typical disease progression seen in this model.

    What this means in real life: The kidneys are extremely energy-hungry organs that rely on healthy mitochondria to filter blood and handle daily stress. When mitochondrial function weakens, renal damage can accelerate. This study shows that (−)-epicatechin can positively influence stress-signaling pathways in the kidney, supporting the cellular energy environment needed for long-term renal resilience.

    Related Content:

    View Paper

    Cognitive Recovery, Inflammation, and Mitochondrial Restoration in Gulf War Illness

    Study Title:
    Neurological Restorative Effects of (-)-Epicatechin in a Model of Gulf War Illness

    Citation:
    Ramírez-Sánchez et al., 2024. Journal of Medicinal Food

    What the Study Found:
    In a rat model of Gulf War Illness, (−)-epicatechin improved both short- and long-term memory performance. It reduced hippocampal oxidative stress, neuroinflammation, and markers of cell death. Most notably, treatment fully restored mitochondrial function markers that had been impaired by the illness.

    What this means in real life:
    Gulf War Illness demonstrates how mitochondrial damage can drive persistent brain fog, memory issues, and chronic inflammation. This study clearly shows that (−)-epicatechin can restore mitochondrial function and, in turn, support cognitive recovery. It highlights why mitochondrial health is central to resilience when the brain faces complex, long-term stress.

    Related Content

    View Paper

    Neuroinflammation, Tau Pathology, and Brain Aging

    Study Title: Effects of (−)-epicatechin on neuroinflammation and hyperphosphorylation of tau in the hippocampus of aged mice

    Citation: Navarrete-Yañez et al., 2020 · Food & Function

    What the Study Found: (−)-Epicatechin reduced oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus of aged mice. These improvements were linked to better markers of cellular health in the brain tissue. The study also reported positive cognitive-related outcomes in the aged model.

    What this means in real life: As mitochondria become less efficient with age, oxidative stress and inflammation can build up and disrupt normal brain proteins such as tau. This study shows that (−)-epicatechin can calm these processes in the hippocampus, helping preserve cellular health where memory is formed. Mitochondrial support is therefore a foundational strategy for maintaining cognitive resilience as we age.

    Related Content:

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community